{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:08:11Z","timestamp":1783901291826,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52227-x","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:24:54Z","timestamp":1778585094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retinal microvasculature changes in long-term consumption of hydroxychloroquine"],"prefix":"10.1038","volume":"16","author":[{"given":"Fariba","family":"Ghassemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahand","family":"Fardad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Salari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diba","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houshang","family":"Faghihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Zarei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Yaseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Ebrahimiadib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"52227_CR1","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","volume":"123","author":"MF Marmor","year":"2016","unstructured":"Marmor, M. F., Kellner, U., Lai, T. Y., Melles, R. B. & Mieler, W. F. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology 123, 1386\u20131394. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.058 (2016).","journal-title":"Ophthalmology"},{"key":"52227_CR2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/0961203309360539","volume":"19","author":"V Peponis","year":"2010","unstructured":"Peponis, V., Kyttaris, V. C., Chalkiadakis, S. E., Bonovas, S. & Sitaras, N. M. Ocular side effects of anti-rheumatic medications: what a rheumatologist should know. Lupus 19, 675\u2013682. https:\/\/doi.org\/10.1177\/0961203309360539 (2010).","journal-title":"Lupus"},{"key":"52227_CR3","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s10787-018-0512-y","volume":"26","author":"SM Monzavi","year":"2018","unstructured":"Monzavi, S. M. et al. Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers. Inflammopharmacology 26, 1175\u20131182 (2018).","journal-title":"Inflammopharmacology"},{"key":"52227_CR4","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1007\/s10067-019-04633-y","volume":"38","author":"H Hanaoka","year":"2019","unstructured":"Hanaoka, H., Iida, H., Kiyokawa, T., Takakuwa, Y. & Kawahata, K. Glucocorticoid, immunosuppressant, hydroxychloroquine monotherapy, or no therapy for maintenance treatment in systemic lupus erythematosus without major organ manifestations. Clin. Rheumatol. 38, 2785\u20132791 (2019).","journal-title":"Clin. Rheumatol."},{"key":"52227_CR5","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/jac\/dkv018","volume":"70","author":"MA Al-Bari","year":"2015","unstructured":"Al-Bari, M. A. Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J. Antimicrob. Chemother. 70, 1608\u20131621. https:\/\/doi.org\/10.1093\/jac\/dkv018 (2015).","journal-title":"J. Antimicrob. Chemother."},{"key":"52227_CR6","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","volume":"132","author":"RB Melles","year":"2014","unstructured":"Melles, R. B. & Marmor, M. F. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 132, 1453\u20131460 (2014).","journal-title":"JAMA Ophthalmol."},{"key":"52227_CR7","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/eye.2016.298","volume":"31","author":"I Yusuf","year":"2017","unstructured":"Yusuf, I., Sharma, S., Luqmani, R. & Downes, S. Hydroxychloroquine retinopathy. Eye 31, 828\u2013845 (2017).","journal-title":"Eye"},{"key":"52227_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.preteyeres.2017.04.005","volume":"59","author":"F Pichi","year":"2017","unstructured":"Pichi, F. et al. The application of optical coherence tomography angiography in uveitis and inflammatory eye diseases. Prog. Retin. Eye Res. 59, 178\u2013201 (2017).","journal-title":"Prog. Retin. Eye Res."},{"key":"52227_CR9","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00417-018-4117-3","volume":"256","author":"M Bulut","year":"2018","unstructured":"Bulut, M. et al. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations. Graefe\u2019s Archive Clin. Experimental Ophthalmol. 256, 2075\u20132081. https:\/\/doi.org\/10.1007\/s00417-018-4117-3 (2018).","journal-title":"Graefe\u2019s Archive Clin. Experimental Ophthalmol."},{"key":"52227_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/02713683.2018.1545912","volume":"44","author":"YS Goker","year":"2019","unstructured":"Goker, Y. S. et al. The Validity of Optical Coherence Tomography Angiography as a Screening Test for the Early Detection of Retinal Changes in Patients with Hydroxychloroquine Therapy. Curr. Eye Res. 44, 311\u2013315. https:\/\/doi.org\/10.1080\/02713683.2018.1545912 (2019).","journal-title":"Curr. Eye Res."},{"key":"52227_CR11","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/bjophthalmol-2018-313679","volume":"105","author":"R Forte","year":"2021","unstructured":"Forte, R., Haulani, H., Dyrda, A. & J\u00fcrgens, I. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests. Br. J. Ophthalmol. 105, 1297. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313679 (2021).","journal-title":"Br. J. Ophthalmol."},{"key":"52227_CR12","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.4103\/ijo.Ijo_740_23","volume":"71","author":"JB Vasilijevi\u0107","year":"2023","unstructured":"Vasilijevi\u0107, J. B. et al. Optical coherence tomography angiography parameters in patients taking hydroxychloroquine therapy. Indian J. Ophthalmol. 71, 3399\u20133405. https:\/\/doi.org\/10.4103\/ijo.Ijo_740_23 (2023).","journal-title":"Indian J. Ophthalmol."},{"key":"52227_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10792-020-01549-4","volume":"41","author":"HN Tarakcioglu","year":"2021","unstructured":"Tarakcioglu, H. N., Ozkaya, A. & Yigit, U. Is optical coherence tomography angiography a useful tool in the screening of hydroxychloroquine retinopathy? Int. Ophthalmol. 41, 27\u201333. https:\/\/doi.org\/10.1007\/s10792-020-01549-4 (2021).","journal-title":"Int. Ophthalmol."},{"key":"52227_CR14","doi-asserted-by":"publisher","first-page":"e0273001","DOI":"10.1371\/journal.pone.0273001","volume":"17","author":"F Salari","year":"2022","unstructured":"Salari, F., Hatami, V., Mohebbi, M. & Ghassemi, F. Assessment of relationship between retinal perfusion and retina thickness in healthy children and adolescents. PLOS ONE. 17, e0273001. https:\/\/doi.org\/10.1371\/journal.pone.0273001 (2022).","journal-title":"PLOS ONE"},{"key":"52227_CR15","doi-asserted-by":"publisher","unstructured":"Ghassemi, F. et al. Quantification of macular perfusion in healthy children using optical coherence tomography angiography. Int. J. Retina Vitreous. 7 https:\/\/doi.org\/10.1186\/s40942-021-00328-2 (2021).","DOI":"10.1186\/s40942-021-00328-2"},{"key":"52227_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4103\/joco.joco_141_23","volume":"35","author":"F Ghassemi","year":"2023","unstructured":"Ghassemi, F. et al. Quantitative Analysis of Inner, Middle, and Outer Retinal Thickness by Optical Coherence Tomography in Children and Adolescents. J. Curr. Ophthalmol. 35, 182\u2013189. https:\/\/doi.org\/10.4103\/joco.joco_141_23 (2023).","journal-title":"J. Curr. Ophthalmol."},{"key":"52227_CR17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/eye.2009.65","volume":"24","author":"S Pasadhika","year":"2010","unstructured":"Pasadhika, S. & Fishman, G. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. Eye 24, 340\u2013346 (2010).","journal-title":"Eye"},{"key":"52227_CR18","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1167\/iovs.14-16345","volume":"56","author":"L de Sisternes","year":"2015","unstructured":"de Sisternes, L., Hu, J., Rubin, D. L. & Marmor, M. F. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea. Investig. Ophthalmol. Vis. Sci. 56, 3415\u20133426 (2015).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"52227_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ajo.2022.07.028","volume":"245","author":"KE 19 Kim","year":"2023","unstructured":"19 Kim, K. E., Kim, Y. H., Kim, J. & Ahn, S. J. Macular ganglion cell complex and peripapillary retinal nerve fiber layer thicknesses in hydroxychloroquine retinopathy. Am. J. Ophthalmol. 245, 70\u201380 (2023).","journal-title":"Am. J. Ophthalmol."},{"key":"52227_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1167\/iovs.14-15138","volume":"56","author":"MG Lee","year":"2015","unstructured":"Lee, M. G. et al. Macular retinal ganglion cell\u2013inner plexiform layer thickness in patients on hydroxychloroquine therapy. Investig. Ophthalmol. Vis. Sci. 56, 396\u2013402 (2015).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"52227_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ophtha.2015.09.011","volume":"123","author":"VS Parikh","year":"2016","unstructured":"Parikh, V. S. et al. Nonleaking cystoid macular edema as a presentation of hydroxychloroquine retinal toxicity. Ophthalmology 123, 664\u2013666 (2016).","journal-title":"Ophthalmology"},{"key":"52227_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-017-0517-0","volume":"17","author":"EH Hong","year":"2017","unstructured":"Hong, E. H., Ahn, S. J., Lim, H. W. & Lee, B. R. The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report. BMC Ophthalmol. 17, 1\u20135 (2017).","journal-title":"BMC Ophthalmol."},{"key":"52227_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.62.12.28","volume":"62","author":"E Borrelli","year":"2021","unstructured":"Borrelli, E. et al. Impact of structural changes on multifocal electroretinography in patients with use of hydroxychloroquine. Investig. Ophthalmol. Vis. Sci. 62, 28\u201328 (2021).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"52227_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40942-016-0042-y","volume":"2","author":"DR Lally","year":"2016","unstructured":"Lally, D. R. et al. Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessation. Int. J. retina vitreous. 2, 1\u201311 (2016).","journal-title":"Int. J. retina vitreous"},{"key":"52227_CR25","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1120672118801125","volume":"29","author":"D Ozek","year":"2019","unstructured":"Ozek, D. et al. The optical coherence tomography angiography findings of rheumatoid arthritis patients taking hydroxychloroquine. Eur. J. Ophthalmol. 29, 532\u2013537 (2019).","journal-title":"Eur. J. Ophthalmol."},{"key":"52227_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1136\/annrheumdis-2018-214235","volume":"78","author":"P Conigliaro","year":"2019","unstructured":"Conigliaro, P. et al. Evaluation of retinal microvascular density in patients affected by systemic lupus erythematosus: an optical coherence tomography angiography study. Ann. Rheum. Dis. 78, 287\u2013289 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"52227_CR27","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/j.ophtha.2016.07.008","volume":"123","author":"C Balaratnasingam","year":"2016","unstructured":"Balaratnasingam, C. et al. Visual acuity is correlated with the area of the foveal avascular zone in diabetic retinopathy and retinal vein occlusion. Ophthalmology 123, 2352\u20132367 (2016).","journal-title":"Ophthalmology"},{"key":"52227_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ajo.2018.08.013","volume":"196","author":"SJ Ahn","year":"2018","unstructured":"Ahn, S. J., Lee, S. U., Lee, S. H. & Lee, B. R. Evaluation of retromode imaging for use in hydroxychloroquine retinopathy. Am. J. Ophthalmol. 196, 44\u201352 (2018).","journal-title":"Am. J. Ophthalmol."},{"key":"52227_CR29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41433-023-02747-x","volume":"38","author":"N Hasan","year":"2024","unstructured":"Hasan, N. et al. Effects of hydroxychloroquine therapy on choroidal volume and choroidal vascularity index. Eye 38, 620\u2013624 (2024).","journal-title":"Eye"},{"key":"52227_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","volume":"23","author":"K Rainsford","year":"2015","unstructured":"Rainsford, K., Parke, A. L., Clifford-Rashotte, M. & Kean, W. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology 23, 231\u2013269 (2015).","journal-title":"Inflammopharmacology"},{"key":"52227_CR31","unstructured":"Dardenne, M. U. Biochemistry of the Eye: Symposium Under the Sponsorship of ISCERG, Ghent, August 1966, Held in Connection with the 20th International Congress of Ophthalmology, Munich, August 1966Karger Medical and Scientific Publishers,. (1968)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52227-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52227-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52227-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:21:12Z","timestamp":1783898472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52227-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52227"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52227-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21714"}}